Literature DB >> 10682278

The stimulation of gene expression by the R region from HTLV-1 and BLV.

J Attal1, M C Théron, G Kann, P Bolifraud, C Puissant, L M Houdebine.   

Abstract

The 5' untranslated regions (5'UTR) of mRNA are known to stimulate or inhibit more or less translation. SR alpha, an association of SV40 early gene promoter and of the R region plus the first 39 nucleotides of the U5 region (designated as R) from the human T-cell leukemia virus (HTLV-1) is currently used to stimulate expression of various coding regions. Its effect is considered to take place at the translational level. In all studies published so far, the R region was associated with the promoter and 5'UTR from SV40 early genes. In the present work, the role of SV40 5'UTR and HTLV-1R region was evaluated separately using different promoters, reporter genes and cells. Both SV40 5'UTR (SU) and R region (R) from HTLV-1 stimulated separately the expression of adjacent reporter genes. When associated, the SV40 5'UTR and the R region from HTLV-1 (SUR) were a more potent stimulator of gene expression and their effects were more than additive. This effect was very potent in HeLa and HC11 cells and almost inexistent in CHO and COS 7 cells. It was of various intensity in other cell types including bird and fish cells. The presence of SUR in gene constructs favoured the accumulation of the mRNAs. SUR stimulated gene expression when added between the cap and the initiation codon. Unexpectedly, SUR was never inhibitory. SUR can therefore be considered essentially as potent and specific stimulator of gene expression favoring mRNA accumulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10682278     DOI: 10.1016/s0168-1656(99)00221-7

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  7 in total

1.  Effect of intercistronic length on internal ribosome entry site (IRES) efficiency in bicistronic mRNA.

Authors:  J Attal; M C Theron; C Puissant; L M Houdebine
Journal:  Gene Expr       Date:  1999

2.  Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.

Authors:  Wataru Akahata; Zhi-yong Yang; Gary J Nabel
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbits.

Authors:  Eric Soler; Agnès Le Saux; Frédéric Guinut; Bruno Passet; Ruxandra Cohen; Christine Merle; Annie Charpilienne; Cynthia Fourgeux; Véronique Sorel; Antoine Piriou; Isabelle Schwartz-Cornil; Jean Cohen; Louis-Marie Houdebine
Journal:  Transgenic Res       Date:  2005-12       Impact factor: 2.788

4.  Viral infection resistance conferred on mice by siRNA transgenesis.

Authors:  Nathalie Daniel-Carlier; Ashraf Sawafta; Bruno Passet; Dominique Thépot; Mathieu Leroux-Coyau; François Lefèvre; Louis-Marie Houdebine; Geneviève Jolivet
Journal:  Transgenic Res       Date:  2012-09-09       Impact factor: 2.788

5.  The 5' untranslated region of the human T-cell lymphotropic virus type 1 mRNA enables cap-independent translation initiation.

Authors:  Eduardo Olivares; Dori M Landry; C Joaquín Cáceres; Karla Pino; Federico Rossi; Camilo Navarrete; Juan Pablo Huidobro-Toro; Sunnie R Thompson; Marcelo López-Lastra
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

6.  RNA helicase A modulates translation of HIV-1 and infectivity of progeny virions.

Authors:  Cheryl Bolinger; Amit Sharma; Deepali Singh; Lianbo Yu; Kathleen Boris-Lawrie
Journal:  Nucleic Acids Res       Date:  2009-12-09       Impact factor: 16.971

7.  RNA helicase A interacts with divergent lymphotropic retroviruses and promotes translation of human T-cell leukemia virus type 1.

Authors:  Cheryl Bolinger; Alper Yilmaz; Tiffiney Roberts Hartman; Melinda Butsch Kovacic; Soledad Fernandez; Jianxin Ye; Mary Forget; Patrick L Green; Kathleen Boris-Lawrie
Journal:  Nucleic Acids Res       Date:  2007-04-10       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.